Treatment of essential hypertension: This fixed dose combination is indicated in adult patients whose blood pressure is not adequately controlled on irbesartan or hydrochlorothiazide alone.
This fixed dose combination is also indicated as initial therapy in patients with moderate to severe essential hypertension for whom the benefit of a prompt blood pressure reduction exceeds the risk of initiating combination therapy in these patients (see Pharmacology: Pharmacodynamics under Actions).